Bank of New York Mellon’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $312K | Sell |
125,672
-81,155
| -39% | -$201K | ﹤0.01% | 3757 |
|
|
2025
Q1 | $321K | Sell |
206,827
-247
| -0.1% | -$383 | ﹤0.01% | 3653 |
|
|
2024
Q4 | $443K | Buy |
207,074
+65,341
| +46% | +$140K | ﹤0.01% | 3564 |
|
|
2024
Q3 | $617K | Buy |
141,733
+32,774
| +30% | +$143K | ﹤0.01% | 3390 |
|
|
2024
Q2 | $508K | Buy |
+108,959
| New | +$508K | ﹤0.01% | 3573 |
|
|
2023
Q2 | – | Sell |
-18,191
| Closed | -$34.4K | – | 4382 |
|
|
2023
Q1 | $34.4K | Hold |
18,191
| – | – | ﹤0.01% | 4247 |
|
|
2022
Q4 | $32.7K | Sell |
18,191
-74
| -0.4% | -$133 | ﹤0.01% | 4292 |
|
|
2022
Q3 | $31K | Hold |
18,265
| – | – | ﹤0.01% | 4386 |
|
|
2022
Q2 | $45K | Sell |
18,265
-69,293
| -79% | -$171K | ﹤0.01% | 4360 |
|
|
2022
Q1 | $243K | Sell |
87,558
-1,993
| -2% | -$5.53K | ﹤0.01% | 4135 |
|
|
2021
Q4 | $477K | Sell |
89,551
-9,833
| -10% | -$52.4K | ﹤0.01% | 3835 |
|
|
2021
Q3 | $841K | Buy |
99,384
+17,889
| +22% | +$151K | ﹤0.01% | 3491 |
|
|
2021
Q2 | $993K | Buy |
81,495
+20,021
| +33% | +$244K | ﹤0.01% | 3425 |
|
|
2021
Q1 | $1.49M | Sell |
61,474
-2,065
| -3% | -$50.1K | ﹤0.01% | 3094 |
|
|
2020
Q4 | $2.04M | Buy |
63,539
+4,934
| +8% | +$158K | ﹤0.01% | 2833 |
|
|
2020
Q3 | $1.77M | Buy |
58,605
+12,076
| +26% | +$365K | ﹤0.01% | 2741 |
|
|
2020
Q2 | $1.96M | Buy |
46,529
+16,082
| +53% | +$678K | ﹤0.01% | 2694 |
|
|
2020
Q1 | $760K | Buy |
+30,447
| New | +$760K | ﹤0.01% | 3151 |
|